Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B

被引:0
|
作者
Kim, D. Y. [1 ]
Lee, J. M. [1 ]
Ahn, S. H. [1 ]
Lee, Y. C. [1 ]
Lee, D. K. [1 ]
Chung, J. B. [1 ]
Chon, C. Y. [1 ]
Han, K-H [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A176 / A176
页数:1
相关论文
共 50 条
  • [41] Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B
    Lampertico, Pietro
    Vigano, Mauro
    Facchetti, Floriana
    Invernizzi, Federica
    Aroldi, Adriana
    Lunghi, Giovanna
    Messa, Pier Giorgio
    Colombo, Massimo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (06) : 2037 - 2041
  • [42] Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus
    Hosaka, T
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Someya, T
    Sezaki, H
    Akuta, N
    Tsubota, A
    Arase, Y
    Ikeda, K
    Kumada, H
    INTERVIROLOGY, 2004, 47 (06) : 362 - 369
  • [43] Two rescue therapies in lamivudine-resistant patients with chronic hepatitis B in the central China: adefovir monotherapy and adefovir plus lamivudine
    Ming Wang
    Leyong Yuan
    Bin Qiao
    Yan Li
    Virus Genes, 2014, 48 : 32 - 37
  • [44] Clinical and virological effects during two years of ongoing adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B infection
    Gornals, JB
    Casanovas, T
    Sabidó, M
    Baliellas, C
    Casanovas, A
    Cañas, C
    Serrano, T
    Verdura, B
    Chahri, N
    Gil-Vernet, S
    Figueras, J
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3957 - 3959
  • [45] Adefovir and lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B
    Lampertico, Pietro
    Marzano, Alfredo
    Levrero, Massimo
    Santantonio, Teresa
    Di Marco, Vito
    Brunetto, Maurizia
    Andreone, Pietro
    Sagnelli, Evangelista
    Fagiuoli, Stefano
    Mazzella, Giuseppe
    Raimondo, Giovanni
    Gaeta, Giovannibattista
    Ascione, Antonio
    HEPATOLOGY, 2006, 44 (04) : 693A - 694A
  • [46] Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant
    Wai, CT
    Prabhakaran, K
    Wee, A
    Lee, YM
    Dan, YY
    Sutedja, DS
    Mak, K
    Isaac, J
    Lee, KH
    Lee, HL
    Da Costa, M
    Lim, SG
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (08) : 2313 - 2314
  • [47] Two rescue therapies in lamivudine-resistant patients with chronic hepatitis B in the central China: adefovir monotherapy and adefovir plus lamivudine
    Wang, Ming
    Yuan, Leyong
    Qiao, Bin
    Li, Yan
    VIRUS GENES, 2014, 48 (01) : 32 - 37
  • [48] Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
    Ahn, Sang-Hoon
    Kweon, Young-Oh
    Paik, Seung-Woon
    Sohn, Joo-Hyun
    Lee, Kwan-Sik
    Kim, Dong Joon
    Piratvisuth, Teerha
    Yuen, Man Fung
    Chutaputti, Anuchit
    Chao, You-Chen
    Trylesinski, Aldo
    Avila, Claudio
    HEPATOLOGY INTERNATIONAL, 2012, 6 (04) : 696 - 706
  • [49] Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
    Sang-Hoon Ahn
    Young-Oh Kweon
    Seung-Woon Paik
    Joo-Hyun Sohn
    Kwan-Sik Lee
    Dong Joon Kim
    Teerha Piratvisuth
    Man Fung Yuen
    Anuchit Chutaputti
    You-Chen Chao
    Aldo Trylesinski
    Claudio Avila
    Hepatology International, 2012, 6 : 696 - 706
  • [50] Surgical treatment of HCC in a patient with lamivudine-resistant hepatitis B cirrhosis with adefovir dipivoxil
    Takashi Akima
    Masaya Tamano
    Hidetsugu Yamagishi
    Keiichi Kubota
    Takahiro Fujimori
    Hideyuki Hiraishi
    World Journal of Hepatology, 2010, (08) : 318 - 321